Molecular Analysis of Chromosome 21 Using Somatic Cell Hybrids a

Down syndrome is the most common specifically identified genetic cause of mental retardation and congenital heart disease in the United States, afflicting one in 700 live-born infants.' In addition, more than 70% of Down syndrome conceptuses may end in spontaneous abortion.2 John Langdon Haydon-Down is credited with first identifying Down syndrome as a unique entity.3 It was first suggested in 19324 that the disease might involve a chromosome defect due to nondisjunction and in 1934 that a trisomy might be invol~ed.~ It was not until 1959, after the correct chromosome number in humans had been determined, that LeJeune was able to show that trisomy of a G-group chromosome was, in fact, associated with Down synd r~me .~ . ' In 1960, the first patient with translocation Down syndrome was described and in 1961 the first case of mosaicism in humans with Down syndrome was Development of banding techniques and the existence of persons with translocation Down syndrome has allowed the pathogenetic region of chromosome 21 to be narrowed down to the band 21q2210,11 and perhaps even to subbands of this regi~n.'~.'"-'~ In some cases in which band q22.1 or band q22.3 was found not to be trisomic, patients were described as having moderate or partial Down syndrome. 13-15 Until definitive biochemical and molecular evidence can be obtained, it is probably most reasonable to consider trisomy

[1]  J. Rowley,et al.  Isolation and analysis of the 21q+ chromosome in the acute myelogenous leukemia 8;21 translocation: evidence that c-mos is not translocated. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[2]  G. Glenner,et al.  Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. , 1984, Biochemical and biophysical research communications.

[3]  M. Olson,et al.  Separation of chromosomal DNA molecules from yeast by orthogonal-field-alternation gel electrophoresis. , 1984, Nucleic acids research.

[4]  P. Nowell,et al.  A human c-erbA oncogene homologue is closely proximal to the chromosome 17 breakpoint in acute promyelocytic leukemia. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Schwartz,et al.  Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis , 1984, Cell.

[6]  G. Reynolds Banbury Report 15, Biological Aspects of Alzheimer's Disease: edited by R. Katzman, Cold Spring Harbor Laboratory, 1983. US $55.00 ($66.00 outside US) (xiv + 495 pages) ISBN 0 87969 213 8 , 1984 .

[7]  A. Clifford,et al.  Effect of dietary purines and pyrimidines on growth and development of Drosophila , 1984 .

[8]  W. Whelan,et al.  Advances in gene technology: Human genetic disorders , 1984 .

[9]  J. Cosgriff,et al.  Hematological abnormalities in newborn infants with Down syndrome. , 1983, American journal of medical genetics.

[10]  W. S. Hayward,et al.  Two human c-onc genes are located on the long arm of chromosome 8. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[11]  O. Mcbride,et al.  Molecular cloning and chromosomal mapping of a human locus related to the transforming gene of Moloney murine sarcoma virus. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[12]  B. Mogilner,et al.  TRANSIENT ACUTE LEUKAEMIA IN A NEWBORN WITH DOWN'S SYNDROME , 1982, Acta paediatrica Scandinavica.

[13]  A. Adelstein,et al.  Mortality and cause of death in Down's syndrome. , 1982, Journal of epidemiology and community health.

[14]  T Scholl,et al.  Leukemia and other Cancers, Anomalies and Infections as Causes of Death in Down's Syndrome in the United States during 1976 , 1982, Developmental medicine and child neurology.

[15]  R. Sparkes,et al.  Down's syndrome phenotype and autosomal gene inactivation in a child with presumed (X;21) de novo translocation. , 1982, Journal of medical genetics.

[16]  N. Heerema,et al.  The myeloproliferative reaction in a child with down syndrome: Cytological and chromosomal evidence for a transient leukemia , 1981, American journal of hematology.

[17]  J. Rowley DOWN SYNDROME AND ACUTE LEUKAEMIA: INCREASED RISK MAY BE DUE TO TRISOMY 21 , 1981, The Lancet.

[18]  P. Layde,et al.  Down's Syndrome: Recent Trends in the United States , 1981 .

[19]  T. Puck,et al.  Two-dimensional electrophoresis of human-CHO cell hybrids containing human chromosome 11 , 1981, Somatic cell genetics.

[20]  U. Francke,et al.  Assignment of the human gene for liver-type 6-phosphofructokinase isozyme (PFKL) to chromosome 21 by using somatic cell hybrids and monoclonal anti-L antibody. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[21]  J. Boué,et al.  Prenatal losses of trisomy 21. , 1981, Human genetics. Supplement.

[22]  H. Wiedemann,et al.  Clinical aspects of Down's syndrome from infancy to adult life. , 1981, Human genetics. Supplement.

[23]  Y. Kaneko,et al.  Chromosome abnormalities in Down's syndrome patients with acute leukemia. , 1981, Blood.

[24]  M. Mattei,et al.  Trisomy 21 for the region 21q223: Identification by high-resolution R-banding patterns , 1981, Human Genetics.

[25]  R. White,et al.  A highly polymorphic locus in human DNA. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[26]  C. Epstein,et al.  Gene dosage effect for glycinamide ribonucleotide synthetase in human fibroblasts trisomic for chromosome 21. , 1980, Biochemical and biophysical research communications.

[27]  A. Chapelle,et al.  Abstracts of meeting presentations (Part 3 of 11) , 1979 .

[28]  P. B. Rowe,et al.  De novo purine synthesis in avian liver. Co-purification of the enzymes and properties of the pathway. , 1978, The Journal of biological chemistry.

[29]  L. Knight Clinical Atlas of Human Chromosomes , 1978 .

[30]  J. Tjio,et al.  The chromosome number of man. , 1978, American journal of obstetrics and gynecology.

[31]  G. Martin Genetic syndromes in man with potential relevance to the pathobiology of aging. , 1978, Birth defects original article series.

[32]  L. Heston,et al.  Alzheimer's Disease, Trisomy 21, and Myeloproliferative Disorders: Associations Suggesting a Genetic Diathesis , 1977, Science.

[33]  W. Valentine,et al.  Hereditary hemolytic anemia with increased red cell adenosine deaminase (45- to 70-fold) and decreased adenosine triphosphate. , 1977, Science.

[34]  M. Becker Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction. , 1976, The Journal of clinical investigation.

[35]  M. Rethoré,et al.  Trisomie 21 et superoxyde dismutase-1 (IPO-A): Tentative de localisation sur la sous bande 21 q 22.1 , 1976 .

[36]  A. Ammann,et al.  NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY IN A CHILD WITH SEVERELY DEFECTIVE T-CELL IMMUNITY AND NORMAL B-CELL IMMUNITY , 1975, The Lancet.

[37]  D. Kochhar,et al.  Limb development in mouse embryos: protection against teratogenic effects of 6-diazo-5-ox-L-norleucine (DON) in vivo and in vitro. , 1975, Journal of embryology and experimental morphology.

[38]  J. Øster,et al.  MORTALITY AND LIFE‐TABLE IN DOWN'S SYNDROME , 1975, Acta paediatrica Scandinavica.

[39]  E. Gelfand,et al.  Severe combined immunodeficiency and adenosine deaminase deficiency. , 1973, The New England journal of medicine.

[40]  G. Schlotterer,et al.  Alzheimer's disease in Down's syndrome: visual retention deficits. , 1974, Cortex; a journal devoted to the study of the nervous system and behavior.

[41]  W. Ellis,et al.  Presenile dementia in Down's syndrome , 1974, Neurology.

[42]  E. Niebuhr,et al.  Down's syndrome , 1974, Humangenetik.

[43]  J. Seegmiller,et al.  Human phosphoribosylpyrophosphate synthetase: increased enzyme specific activity in a family with gout and excessive purine synthesis. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[44]  E. Giblett,et al.  Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity. , 1972, Lancet.

[45]  C. Shaw,et al.  Presenile dementia and Alzheimer's disease in mongolism. , 1969, Brain : a journal of neurology.

[46]  W L Nyhan,et al.  A new disorder of purine metabolism with behavioral manifestations. , 1969, The Journal of pediatrics.

[47]  C. V. Van Nevel,et al.  Hyperuricosuric encephalopathy without hyperuricaemia. , 1968, Archives of disease in childhood.

[48]  J. Seegmiller,et al.  Variations in purine metabolism of cultured skin fibroblasts from patients with gout. , 1968, The Journal of clinical investigation.

[49]  E. Mertz,et al.  Metabolism of N15 labeled uric acid in Down's syndrome. , 1968, Metabolism: clinical and experimental.

[50]  H. Moser,et al.  Hyperuricemia in Down's syndrome. , 1968, The Journal of clinical endocrinology and metabolism.

[51]  J. Seegmiller,et al.  Mental retardation, self-mutilation and hyperuricemia in females. , 1968, Transactions of the American Neurological Association.

[52]  E. Mertz,et al.  Clearance of uric acid, urea, and creatinine in Down's syndrome. , 1967, Journal of applied physiology.

[53]  J. Seegmiller,et al.  A specific enzyme defect in gout associated with overproduction of uric acid. , 1967, Proceedings of the National Academy of Sciences of the United States of America.

[54]  J. Seegmiller,et al.  Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis , 1967, Science.

[55]  W. Nyhan,et al.  A FAMILIAL DISORDER OF URIC ACID METABOLISM AND CENTRAL NERVOUS SYSTEM FUNCTION. , 1964, The American journal of medicine.

[56]  C. E. Ford,et al.  21 TRISOMY/NORMAL MOSAICISM IN AN INTELLIGENT CHILD WITH SOME MONGOLOID CHARACTERS. , 1963, Lancet.

[57]  Amala Chaudhuri,et al.  The chromosome number in man , 1963, Indian journal of pediatrics.

[58]  R. Fuller,et al.  Serum Uric Acid in Mongolism , 1962, Science.

[59]  C. Clarke,et al.  21-TRISOMY/NORMAL MOSAICISM , 1961 .

[60]  C. E. Ford,et al.  A Mongol girl with 46 chromosomes. , 1960, Lancet.

[61]  J. Thiersch Effect of 6 Diazo 5 Oxo L-Norleucine (DON) on the Rat Litter in Utero. ∗ , 1957, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[62]  A. Bleyer INDICATIONS THAT MONGOLOID IMBECILITY IS A GAMETIC MUTATION OF DEGRESSIVE TYPE , 1934 .

[63]  P. J. Waardenburg Das menschliche Auge und seine Erbanlagen , 1932 .